Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327960057> ?p ?o ?g. }
- W4327960057 endingPage "2384" @default.
- W4327960057 startingPage "2384" @default.
- W4327960057 abstract "(1) Background: Chemokines and chemokine receptors play an important role in tumor development. The aim of this study was to check the significance of CCL5 and CCR1 variants with response rate, survival, and the level of regulated on activation, normal T cells expressed and secreted (RANTES/CCL5) in multiple myeloma (MM) patients; (2) Methods: Genomic DNA from 101 newly diagnosed MM patients and 100 healthy blood donors were analyzed by Real-time PCR method (for CCL5 and CCR1 genotyping). In a subgroup of 70 MM patients, serum samples were collected to determine the level of RANTES; (3) Results: multivariate Cox regression showed increased risk of disease relapse or progression (HR = 4.77; p = 0.01) in MM patients with CG + CC genotypes of CCL5 rs2280788. In contrast, CT + TT genotypes of CCL5 rs2107538 were associated withdecreased risk of death (HR = 0.18; p = 0.028) and disease relapse or progression (HR = 0.26; p = 0.01). In MM patients with major genotypes of rs2280789, rs2280788, and rs2107538, higher survival rates were observed in response to treatment with thalidomide and bortezomib. Statistically significant lower RANTES levels were seen in minor genotypes and heterozygotes of CCL5 and CCR1 variants; (4) Conclusions: Major genotypes of CCL5 variants may be independent positive prognostic factors in MM." @default.
- W4327960057 created "2023-03-21" @default.
- W4327960057 creator A5015030040 @default.
- W4327960057 creator A5022347549 @default.
- W4327960057 creator A5022505981 @default.
- W4327960057 creator A5063902005 @default.
- W4327960057 creator A5067770681 @default.
- W4327960057 creator A5075017425 @default.
- W4327960057 creator A5078646616 @default.
- W4327960057 creator A5088482559 @default.
- W4327960057 date "2023-03-20" @default.
- W4327960057 modified "2023-09-27" @default.
- W4327960057 title "The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma" @default.
- W4327960057 cites W1513564680 @default.
- W4327960057 cites W1861735264 @default.
- W4327960057 cites W1892403101 @default.
- W4327960057 cites W1965737177 @default.
- W4327960057 cites W1972566875 @default.
- W4327960057 cites W1981427065 @default.
- W4327960057 cites W1987835263 @default.
- W4327960057 cites W1995557161 @default.
- W4327960057 cites W2003409252 @default.
- W4327960057 cites W2003734726 @default.
- W4327960057 cites W2007402176 @default.
- W4327960057 cites W2013624045 @default.
- W4327960057 cites W2020457207 @default.
- W4327960057 cites W2032434507 @default.
- W4327960057 cites W2033393138 @default.
- W4327960057 cites W2034952320 @default.
- W4327960057 cites W2041469831 @default.
- W4327960057 cites W2044436186 @default.
- W4327960057 cites W2059695760 @default.
- W4327960057 cites W2062202682 @default.
- W4327960057 cites W2068547289 @default.
- W4327960057 cites W2071217825 @default.
- W4327960057 cites W2081616641 @default.
- W4327960057 cites W2092833546 @default.
- W4327960057 cites W2094606125 @default.
- W4327960057 cites W2127909824 @default.
- W4327960057 cites W2133868657 @default.
- W4327960057 cites W2134486617 @default.
- W4327960057 cites W2139171427 @default.
- W4327960057 cites W2141053481 @default.
- W4327960057 cites W2142583019 @default.
- W4327960057 cites W2147423551 @default.
- W4327960057 cites W2148926267 @default.
- W4327960057 cites W2150616055 @default.
- W4327960057 cites W2152124092 @default.
- W4327960057 cites W2161984863 @default.
- W4327960057 cites W2167579918 @default.
- W4327960057 cites W2316274163 @default.
- W4327960057 cites W2347029420 @default.
- W4327960057 cites W2461837629 @default.
- W4327960057 cites W2600005758 @default.
- W4327960057 cites W2757493176 @default.
- W4327960057 cites W2795633384 @default.
- W4327960057 cites W2803537101 @default.
- W4327960057 cites W2889058133 @default.
- W4327960057 cites W2905439552 @default.
- W4327960057 cites W2979723652 @default.
- W4327960057 cites W2983967358 @default.
- W4327960057 cites W2988531462 @default.
- W4327960057 cites W3033365407 @default.
- W4327960057 cites W3033984710 @default.
- W4327960057 cites W3035813128 @default.
- W4327960057 cites W3039069304 @default.
- W4327960057 cites W3127064939 @default.
- W4327960057 cites W4205261080 @default.
- W4327960057 cites W4210734847 @default.
- W4327960057 cites W4290988577 @default.
- W4327960057 cites W880640307 @default.
- W4327960057 doi "https://doi.org/10.3390/jcm12062384" @default.
- W4327960057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36983384" @default.
- W4327960057 hasPublicationYear "2023" @default.
- W4327960057 type Work @default.
- W4327960057 citedByCount "0" @default.
- W4327960057 crossrefType "journal-article" @default.
- W4327960057 hasAuthorship W4327960057A5015030040 @default.
- W4327960057 hasAuthorship W4327960057A5022347549 @default.
- W4327960057 hasAuthorship W4327960057A5022505981 @default.
- W4327960057 hasAuthorship W4327960057A5063902005 @default.
- W4327960057 hasAuthorship W4327960057A5067770681 @default.
- W4327960057 hasAuthorship W4327960057A5075017425 @default.
- W4327960057 hasAuthorship W4327960057A5078646616 @default.
- W4327960057 hasAuthorship W4327960057A5088482559 @default.
- W4327960057 hasBestOaLocation W43279600571 @default.
- W4327960057 hasConcept C10515644 @default.
- W4327960057 hasConcept C116484652 @default.
- W4327960057 hasConcept C126322002 @default.
- W4327960057 hasConcept C13373296 @default.
- W4327960057 hasConcept C143998085 @default.
- W4327960057 hasConcept C170493617 @default.
- W4327960057 hasConcept C203014093 @default.
- W4327960057 hasConcept C2776090121 @default.
- W4327960057 hasConcept C2776364478 @default.
- W4327960057 hasConcept C50382708 @default.
- W4327960057 hasConcept C71924100 @default.
- W4327960057 hasConcept C79484868 @default.